Peering Into Regeneron Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals's (NYSE:REGN) short percent of float has risen 9.4% since its last report, with 1.48 million shares sold short, which is 1.63% of all regular shares available for trading. This increase in short interest can signal that investors have become more bearish. However, compared to its peers, Regeneron has less short interest as a percentage of float, which is 3.58% on average.
September 14, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals's short percent of float has risen 9.4%, indicating a potentially bearish sentiment among investors. However, compared to its peers, the company has less short interest.
The increase in short interest indicates that more investors are betting that the price of Regeneron's stock will fall. This could put downward pressure on the stock price in the short term. However, the fact that Regeneron has less short interest compared to its peers could mitigate this effect to some extent.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100